Latest News

genedrive soars as it confirms receipt of Indian import licence for COVID-19 test

0

genedrive PLC (LON:GDR) shares surged on Friday after the diagnostics firm confirmed it has received a licence to import its COVID-19 testing kit into India through its partner DIVOC Health.

The AIM-listed firm said the licence follows approval of the product by the Indian Centre for Medical Research on April 30.

READ: genedrive COVID-19 PCR test approved by the Indian regulator

genedrive added that India has introduced pricing controls in its routine public testing market that favours the provision of lower cost/basic tests than its own kit. As a result, the firm said it is continuing to assess specific commercial opportunities with DIVOC Health in the Indian public and private markets.

The company’s shares were up 25.2% at 62p in mid-afternoon trading.

CRH, Ashtead get boost from US infrastructure deal

Previous article

Nike to make like Air Jordan after sales hit quarterly record

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News